Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reviews in Endocrine and Metabolic Disorders
Published in: Reviews in Endocrine and Metabolic Disorders 2/2013

01-06-2013

Insights into tandem mass spectrometry for the laboratory endocrinology

Authors: Uberto Pagotto, Flaminia Fanelli, Renato Pasquali

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 2/2013

Login to get access

Excerpt

In the last decade a great deal of data were produced by the scientific community on the analytical improvements introduced by liquid chromatography—tandem mass spectrometry (LC-MS/MS) in the research and clinical fields. This technology is nowadays recognized as the most promising for the quantitation of small molecules in biological fluids. LC-MS/MS combines the practicability of LC and the inherent elevated sensitivity and specificity of MS. Its potential in terms of improved practicability and sample throughput represent the hope for a definitive reconciliation between quality, economy and productivity of assays for clinical laboratories. …
Metadata
Title
Insights into tandem mass spectrometry for the laboratory endocrinology
Authors
Uberto Pagotto
Flaminia Fanelli
Renato Pasquali
Publication date
01-06-2013
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 2/2013
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-013-9250-z

Other articles of this Issue 2/2013

Reviews in Endocrine and Metabolic Disorders 2/2013 Go to the issue

OriginalPaper

Vitamin D and metabolites measurement by tandem mass spectrometry

OriginalPaper

Bone and vitamin D metabolism in HIV

OriginalPaper

HIV and thyroid dysfunction

OriginalPaper

Revisiting hyper- and hypo-androgenism by tandem mass spectrometry

OriginalPaper

Human immune deficiency virus (HIV) infection and the hypothalamic pituitary adrenal axis

OriginalPaper

Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits